| Status | Topic selection |
| Technology type | Medicine |
| Decision | Selected |
| Reason for decision | Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources |
| Further information | Decision makers have concluded that this technology will not progress as a potential technology appraisal or a highly specialised technology. Traditional approaches to cost-effectiveness analysis, as used in TA, are not appropriate for antimicrobials. New antimicrobials will now be considered for NICE evaluation as part of NHS England’s Antimicrobial Products Subscription Model. Therefore, an evaluation of this product would not be appropriate. |
| ID number | 12035 |
Project Team
| Project lead | Danielle Lees |
Email enquiries
- If you have any queries please email topic.selection@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 04 July 2024 | Topic selection |
For further information on how we select topics for development, please see our page about topic selection